Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05271136 · ClinicalTrials.gov registry record · NA

A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum

A NA study of Wrinkle and Photoaging, sponsored by Revision Skincare.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT05271136 is a NA study of Wrinkle and Photoaging that has completed, run by Revision Skincare. The registered enrollment target is 26 participants, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05271136, a NA study of Wrinkle and Photoaging, has completed, sponsored by Revision Skincare.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This double-blind, randomized, controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging serum to improve moderate overall photodamage and skin fatigue of aging skin after 7 days of twice-daily use when compared to the efficacy of a combination of anti-aging serum and an anti-aging facial moisturizer. A total of 26 female subjects, aged 34-60, completed study participation.

Interventions

  • OTHER Facial Moisturizer
  • OTHER Sunscreen
  • OTHER Anti-aging Serum
  • OTHER Cleansing Lotion

Study Locations (1)

Texas

  • SGS Stephens, Inc. - Richardson

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-09-30
Est. Completion 2020-10-13
Phase NA

Sponsor

Revision Skincare

18 total trials

What the Registry Record Tells You About NCT05271136

The ClinicalTrials.gov registry entry for NCT05271136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (78% lower). The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 4 interventions - of which Facial Moisturizer is the first listed.

NCT05271136 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05271136 about?

NCT05271136 is a clinical study titled "A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum". This double-blind, randomized, controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging serum to improve moderate overall photodamage and skin fatigue of aging skin after 7 days of twice-daily use when compared to the efficacy of a combination of a...

What is the current status of trial NCT05271136?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-09-30. Estimated completion is 2020-10-13.

What conditions does trial NCT05271136 study?

This clinical trial studies the following conditions: Wrinkle, Photoaging, Fine Lines.

What interventions are being tested in trial NCT05271136?

The interventions under investigation include: Facial Moisturizer (OTHER), Sunscreen (OTHER), Anti-aging Serum (OTHER), Cleansing Lotion (OTHER).

Who is sponsoring clinical trial NCT05271136?

This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05271136 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.